Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0F4AW
|
|||
| Drug Name |
Indol-5-ol derivative 1
|
|||
| Synonyms |
PMID25656651-Compound-41
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
NANT HOLDINGS IP, LLC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C24H26F2N8O
|
|||
| Canonical SMILES |
CC1=CC2=C(C(=CC(=C2N1)F)OC3=NC(=CC(=N3)N4CCN(CC4)C)NC5=NNC(=C5)C6CC6)F
|
|||
| InChI |
1S/C24H26F2N8O/c1-13-9-15-22(26)18(10-16(25)23(15)27-13)35-24-29-19(28-20-11-17(31-32-20)14-3-4-14)12-21(30-24)34-7-5-33(2)6-8-34/h9-12,14,27H,3-8H2,1-2H3,(H2,28,29,30,31,32)
|
|||
| InChIKey |
UUZGSTUXCIFCOJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.